William Enright
Net worth: 4 696 $ as of 2026-09-29
Net worth: 4 696 $ as of 2026-09-29
Mr. William Enright is an Independent Non-Executive Director at BullFrog AI Holdings, Inc., a Chief Executive Officer & Director at Barinthus Biotherapeutics Plc and a Chief Executive Officer & Director at Barinthus Biotherapeutics (UK) Ltd. He is on the Board of Directors at BullFrog AI Holdings, Inc., Gravitas Therapeutics, Inc., Barinthus Biotherapeutics Plc and Barinthus Biotherapeutics (UK) Ltd. Mr. Enright was previously employed as a President, Chief Executive Officer & Director by Altimmune, Inc., a Director-Research & Development by Wellstat Biologics Corp., a Head-Business Development by GenVec, Inc., a Chief Scientific Officer by ImQuest BioSciences, Inc., a Principal by Life Technologies Corp., and a Scientist by State University of New York at Buffalo.
He received his undergraduate degree from State University of New York at Buffalo, a graduate degree from The Johns Hopkins University School of Medicine and a graduate degree from State University of New York at Buffalo.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-10 | 7,813 ( 0.04% ) | 4 696 $ | 2026-09-29 |
| Companies | Position | Start |
|---|---|---|
| BARINTHUS BIOTHERAPEUTICS ADR | Chief Executive Officer | 2019-07-31 |
| BULLFROG AI HOLDINGS, INC. | Director/Board Member | 2023-02-13 |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Chief Executive Officer | 2019-08-27 |
Gravitas Therapeutics, Inc.
Gravitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical-stage antifungal for treatment of aspergillus mold infections | Director/Board Member | 2021-12-31 |
| Companies | Position | End |
|---|---|---|
| ALTIMMUNE, INC. | Chief Executive Officer | 2018-11-29 |
Wellstat Biologics Corp.
Wellstat Biologics Corp. Pharmaceuticals: MajorHealth Technology Operates as development and commercialization of biological agents | Chief Tech/Sci/R&D Officer | 2010-09-30 |
ImQuest BioSciences, Inc.
ImQuest BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates preclinical contract research and development organization for biotechnology and pharmaceutical industries | Chief Tech/Sci/R&D Officer | - |
State University of New York at Buffalo
State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
GenVec, Inc.
GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
State University of New York at Buffalo
State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Wellstat Biologics Corp.
Wellstat Biologics Corp. Pharmaceuticals: MajorHealth Technology Operates as development and commercialization of biological agents | Health Technology |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImQuest BioSciences, Inc.
ImQuest BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates preclinical contract research and development organization for biotechnology and pharmaceutical industries | Commercial Services |
Altimmune, Inc.
Altimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
BullFrog AI Holdings, Inc.
BullFrog AI Holdings, Inc. Packaged SoftwareTechnology Services Develops an artificial intelligence and machine learning platform for clinical and pharmaceutical industry | Technology Services |
Vaccitech Plc
Vaccitech Plc Pharmaceuticals: MajorHealth Technology Discovers and develops immunotherapeutic products and vaccines for the treatment and prevention of infectious and cancer diseases | Health Technology |
Gravitas Therapeutics, Inc.
Gravitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical-stage antifungal for treatment of aspergillus mold infections | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions